Patients with metastatic breast cancer using bevacizumab as a treatment: is there still a role for it?

Current Treatment Options in Oncology
Ana Elisa Lohmann, Stephen K Chia

Abstract

Over the last few decades, the angiogenesis mechanism has increasingly been studied and implicated in cancer pathophysiology. At present, it is known that angiogenesis plays a relevant role in tumor growth, and more importantly many new molecules exists can potentially interfere with this process. Bevacizumab, a humanized monoclonal antibody targeting the vascular endothelial growth factor A (VEGF-A) now commonly used in the treatment of colorectal, renal cell, and brain cancer, is the first anti-angiogenesis drug delivered in combination with chemotherapy that has consistently shown clinical efficacy in the treatment of breast cancer. Since the ECOG 2100 trial has shown that bevacizumab added to paclitaxel as a first-line treatment for advanced breast cancer nearly doubled the time to progression and tumor response rate, its approval was granted almost worldwide. However, other phase III trials revealed a smaller absolute improvement in progression-free survival (PFS) and response rates, and no trials yet have demonstrated survival enhancement which led to a great controversy and debate over the use of bevacizumab. The discrepancy between PFS and overall survival also raises the question of whether or not bevacizumab has been ...Continue Reading

References

Aug 19, 1992·Journal of the National Cancer Institute·F SpyratosM Brunet
Sep 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·B OlofssonU Eriksson
Oct 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R FossatiA Liberati
Mar 5, 1999·Breast Cancer Research and Treatment·M D PegramD J Slamon
Aug 30, 2000·Nature·C M PerouD Botstein
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Jun 18, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joyce O'ShaughnessyRobert Leonard
Jul 27, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P B VermeulenL Y Dirix
Oct 3, 2002·Nature Reviews. Cancer·Napoleone Ferrara
May 12, 2004·Nature Reviews. Drug Discovery·Napoleone FerraraWilliam Novotny
Dec 9, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel J Hicklin, Lee M Ellis
Feb 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kathy D MillerHope S Rugo
Dec 13, 2005·Experimental Cell Research·Masabumi Shibuya, Lena Claesson-Welsh
Oct 4, 2006·The Journal of Clinical Investigation·Michael R MancusoDonald M McDonald
Dec 28, 2007·The New England Journal of Medicine·Kathy MillerNancy E Davidson
Apr 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martine J Piccart-GebhartPatrick Therasse
Apr 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tomasz BurzykowskiPatrick Therasse
Aug 16, 2008·The New England Journal of Medicine·Gianpaolo ZerbiniAlessio Palini
Aug 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kathy S AlbainJoyce O'Shaughnessy
Sep 16, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ferry A L M Eskens, Stefan Sleijfer
Sep 17, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Silvia DellapasquaMarco Colleoni
Jan 17, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Konstantin J DedesThomas D Szucs
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert GrayRobert L Comis
Oct 21, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tiffany A TrainaMaura N Dickler
Jan 12, 2010·Breast Cancer Research and Treatment·A ValachisD Mauri
Feb 20, 2010·European Cytokine Network·Napoleone Ferrara
May 14, 2010·Biochimica Et Biophysica Acta·Shanchun GuoRuben R Gonzalez-Perez
May 26, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David W MilesGilles Romieu
Jul 9, 2010·CA: a Cancer Journal for Clinicians·Ahmedin JemalElizabeth Ward
Jul 14, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G von MinckwitzUNKNOWN German Breast Group and Arbeitsgemeinschaft Gynäkologische Onkologie-Brust investigators
Nov 26, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David MilesFlorin Sirzén
Dec 4, 2010·The Lancet Oncology·Adrian M Jubb, Adrian L Harris
Jan 6, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Toni K ChoueiriFabio A B Schutz
Feb 3, 2011·JAMA : the Journal of the American Medical Association·Vishal RanpuraShenhong Wu
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
May 11, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hope S RugoDenis Soulieres

❮ Previous
Next ❯

Citations

Sep 25, 2012·Nature Reviews. Cancer·Barbara Sennino, Donald M McDonald
Apr 4, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dipen MaruLee M Ellis
Dec 20, 2020·Cancers·Stephanie AnnettTracy Robson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Related Papers

Drug Safety : an International Journal of Medical Toxicology and Drug Experience
Rodrigo DienstmannOtto Metzger-Filho
Breast Cancer Research : BCR
Bryan P Schneider, George W Sledge
© 2022 Meta ULC. All rights reserved